| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:Prostaglandin B3
CAS:36614-32-1
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:Prostaglandin B3
CAS:36614-32-1
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:Prostaglandin B3
CAS:36614-32-1
Purity:>97% Package:25μg;50μg;100μg
|
| Company Name: |
Cayman Chemical Company
|
| Tel: |
(800) 364-9897 |
| Email: |
cayman@caymanchem.com |
| Products Intro: |
Product Name:Prostaglandin B3
CAS:36614-32-1
Package:>97% Remarks:11990
|
|
| | 9-OXO-15S-HYDROXY-PROSTA-5Z,8(12),13E,17Z-TETRAEN-1-OIC ACID Basic information |
| Product Name: | 9-OXO-15S-HYDROXY-PROSTA-5Z,8(12),13E,17Z-TETRAEN-1-OIC ACID | | Synonyms: | 9-OXO-15S-HYDROXY-PROSTA-5Z,8(12),13E,17Z-TETRAEN-1-OIC ACID;PROSTAGLANDIN B3;(5Z,13E,15S,17Z)-15-Hydroxy-9-oxoprosta-5,8(12),13,17-tetraen-1-oic acid;PGB3;DQRGQQAJYRBDRP-UNBCGXALSA-N;7-[2-[(3S)-3-hydroxyocta-1,5-dienyl]-5-oxocyclopenten-1-yl]hept-5-enoic acid;Prosta-5,8(12),13,17-tetraen-1-oic acid, 15-hydroxy-9-oxo-, (5Z,13E,15S,17Z)- | | CAS: | 36614-32-1 | | MF: | C20H28O4 | | MW: | 332.43 | | EINECS: | | | Product Categories: | | | Mol File: | 36614-32-1.mol |  |
| | 9-OXO-15S-HYDROXY-PROSTA-5Z,8(12),13E,17Z-TETRAEN-1-OIC ACID Chemical Properties |
| Boiling point | 548.8±50.0 °C(Predicted) | | density | 1.135±0.06 g/cm3(Predicted) | | solubility | DMF: >75 mg/ml (from PGB2); DMSO: >50 mg/ml (from PGB2); Ethanol: >100 mg/ml (from PGB2); PBS pH 7.2: >2 mg/ml (from PGB2) | | pka | 4.74±0.10(Predicted) |
| | 9-OXO-15S-HYDROXY-PROSTA-5Z,8(12),13E,17Z-TETRAEN-1-OIC ACID Usage And Synthesis |
| Description | Prostaglandin B3 (PGB3) is a non-enzymatic dehydration product resulting from the treatment of Prostaglandin E3 (PGE3) with strong base. In a structure-activity binding study to determine the affinity of various prostaglandins to human PPARγ, PGB3 exhibited a Ki value greater than 1 mM. In contrast, PGB1 and PGB2 showed significantly higher affinity for PPARγ, with Ki values of 26 and 77 μM, respectively, the same assay. |
| | 9-OXO-15S-HYDROXY-PROSTA-5Z,8(12),13E,17Z-TETRAEN-1-OIC ACID Preparation Products And Raw materials |
|